Laura Bobolts, PharmD, BCOP: It’s an exciting time in the landscape of patient-support services for patients with cancer in general, whether they’re patients with upper–GI [gastrointestinal] and ...

Patients aren’t the only healthcare participants who believe self-care is necessary since the COVID-19 pandemic – 86.6% of healthcare professionals now believe so, too. However, connecting patients ...

About 1 in 10 prescription drugs — mainly brand-name and expensive drugs and those for rare diseases — has a manufacturer-sponsored patient support program, which usually includes financial, nursing ...

Barbara LaCoste reads with a magnifier device supplied by the Patient Support Program. Four years ago, Barbara LaCoste began seeing blurry spots in her central line of vision. During an eye exam at ...

Pharmaceutical companies are undergoing a profound transformation. No longer confined to merely developing treatments, companies are assuming a partnership role to collaborate with healthcare ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed and Health Law Scan, focusing on issues impacting the rare disease community.

On this Ropes & Gray podcast, health care partner Michael Lampert and counsel Sam Perrone, and litigation & enforcement partner Andrew O’Connor, rejoin to discuss patient assistance programs, recent ...

Anna Sutton was shocked when she received a letter from her husband’s job-based health plan stating that Humira, an expensive drug used to treat her daughter’s juvenile arthritis, was now on a long ...

Anna Sutton was shocked when she received a letter from her husband's job-based health plan stating that Humira, an expensive drug used to treat her daughter's juvenile arthritis, was now on a long ...

Gemtesa’s manufacturer (Urovant Sciences) provides the Gemtesa Simple Savings Program. This is a financial assistance plan aimed at making Gemtesa (vibegron) — a treatment for overactive bladder in ...

Greater transparency and independent evaluation are needed to understand the impact of the patient support programs that pharmaceutical companies offer for many expensive drugs, according to ...

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...